CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BCL10 is an immune signaling adaptor mostly expressed in lymphocytes. It has a key role in lymphocyte activation through the nuclear factor-kappa B pathway28.”
From Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation (2024) · cites this paper as [28]
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089 · cited 1×
“It is well established that antigen-receptor triggering leads to a marked and rapid induction of tyrosine phosphorylation through the activation of SRC- and SYK-family kinase”
BackgroundThemes and variations on ubiquitylation
Weissman, A. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056563 · Cited by 1,482
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
Roy, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6914 · Cited by 1,301 · cited 1×
“Alternatively, the BIR-domain-containing amino terminus of the cIAP–MALT1 fusion protein might confer anti-apoptotic activity by directly inhibiting caspase”
BackgroundHirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,153
Uren (2000) · Molecular Cell · Cited by 965
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938 · cited 1×
“cgi?l=7409">VAV1 by the TCR and CD28, as well as recruitment and enrichment of lipid rafts in the T cell–antigen-presenting cell (APC) contact are”
BackgroundPKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892 · cited 1×
“cgi?l=5579">PKC-β have a key role in TCR- and BCR-induced NF-κB activation, respectivel”
BackgroundMartin, F., & Kearney, J. F. (2002) · Nature Reviews Immunology · doi:10.1038/nri799 · Cited by 860
Cited by
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
“Although Bcl10-deficient and MALT1-deficient mice have been generated, and used to confirm the role of these molecules in NF-κB activatio”
MethodTargeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,135
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
“78, 79 PKC θ and PKC β mediate the interaction between TAK1 and CARMA1 and recruit IKK, which activates downstream NF-κ B signaling.”
BackgroundChronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science's STKE · doi:10.1126/stke.3572006re13 · Cited by 1,274
“function has been substantiated by gene disruption and forward genetic screens (137) (Fig.”
BackgroundHayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
“Most likely this was due to the loss of signaling to NF-kB in these cells because loss of IKKb, NEMO or components of the CBM complex in mature B cells also results in a complete loss of peripheral B cells (Pasparakis et al., 2002; Li et al., 2003; Thome, 2004).”
BackgroundHayden, M. S., & Ghosh, S. (2011) · Cell Research · doi:10.1038/cr.2011.13 · Cited by 1,117
Essential function for the kinase TAK1 in innate and adaptive immune responses
Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1255 · Cited by 973
“A complex of the signaling molecules CARD11 (also known as CARMA1), Bcl10 and MALT1 (also known as paracaspase) then transduces signals to NF-κB and MAPKs downstream of protein kinase C-&beta”
BackgroundOncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity
Gross, O., Gewies, A., Finger, K., Schäfer, M., Sparwasser, T., Peschel, C., Förster, I., & Ruland, J. (2006) · Nature · doi:10.1038/nature04926 · Cited by 853
Life and death in peripheral T cells
Krammer, P. H., Arnold, R., & Lavrik, I. N. (2007) · Nature Reviews Immunology · doi:10.1038/nri2115 · Cited by 653
IκB kinase complexes: gateways to NF-κB activation and transcription
Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 651
“…(see Hayden et al., 2006), all components of Oncogene the caspase-recruitment-domain-containing membraneassociated guanylate (CARMA1)–Bcl10–mucosaassociated lymphoid tissue lymphoma translocation protein 1 (MALT1) (CBM) complex are essential for IKK and NF-kB activation (Thome, 2004) (Figure 3).”
BackgroundA loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
NF‐κB signaling in inflammation and cancer
Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021) · MedComm · doi:10.1002/mco2.104 · Cited by 574
The Death Domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation
Park, H. H., Lo, Y.-C., Lin, S.-C., Wang, L., Yang, J. K., & Wu, H. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141656 · Cited by 526
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 521
“Since CARD11 coordinates the activation of IKK (Thome, 2004), the key regulatory kinase in the classical NF-kB pathway, we assessed IKK function using an ABC DLBCL reporter line engineered to express a fusion protein between luciferase and the IKK substrate IkBa (Lam et al.”
MethodStaudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485
Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development
Hwang, J.-R., Byeon, Y., Kim, D., & Park, S.-G. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0435-8 · Cited by 470
Pathogenesis of Human B Cell Lymphomas
Shaffer, A. L., Young, R. M., & Staudt, L. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075027 · Cited by 437
Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor
Su, H., Bidère, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., & Lenardo, M. (2005) · Science · doi:10.1126/science.1104765 · Cited by 429
Targeting pathological B cell receptor signalling in lymphoid malignancies
Young, R. M., & Staudt, L. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3937 · Cited by 401
B Cell Signaling and Fate Decision
Kurosaki, T., Shinohara, H., & Baba, Y. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132541 · Cited by 351
B-1 B Cell Development in the Fetus and Adult
Montecino-Rodriguez, E., & Dorshkind, K. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.017 · Cited by 351
Antigen-Receptor Signaling to Nuclear Factor κB
Schulze-Luehrmann, J., & Ghosh, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.010 · Cited by 330
Roles of the NF- B Pathway in Lymphocyte Development and Function
Gerondakis, S., & Siebenlist, U. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000182 · Cited by 320
“, Carma1, Malt1, Bcl-10, TRAF6, and Tak1) (Thome 2004; Pappu and Lin 2006; Kobayashi et al. 2009; Schuman et al. 2009).”
BackgroundInfluentialThe proteolytic activity of the paracaspase MALT1 is key in T cell activation
Rebeaud, F., Hailfinger, S., Posevitz-Fejfar, A., Tapernoux, M., Moser, R., Rueda, D., Gaide, O., Guzzardi, M., Iancu, E. M., Rufer, N., et al. (2008) · Nature Immunology · doi:10.1038/ni1568 · Cited by 310
“dtd" [ ]> Bcl-10 and MALT1 are signaling proteins that are key in antigen receptor–mediated lymphocyte activation and lymphomagenesi”
Self-citationCaspases at the crossroads of immune-cell life and death
Siegel, R. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1809 · Cited by 305
“This complex is a key mediator of NF-κB activation after stimulation of B and T cells through their antigen receptor”
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
Genetics of diffuse large B-cell lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2018) · Blood · doi:10.1182/blood-2017-11-764332 · Cited by 282
cFLIP regulation of lymphocyte activation and development
Budd, R. C., Yeh, W.-C., & Tschopp, J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1787 · Cited by 280
Control of lymphocyte development by nuclear factor-κB
Siebenlist, U., Brown, K., & Claudio, E. (2005) · Nature Reviews Immunology · doi:10.1038/nri1629 · Cited by 272
“PKC-β might have a role that is analogous to the role of PKC-t in the TCR-signalling pathway that involves IKKs and NF-κB in mature T cell”
Wan, Y. Y., Chi, H., Xie, M., Schneider, M. D., & Flavell, R. A. (2006) · Nature Immunology · doi:10.1038/ni1355 · Cited by 262
“in a pathway 'downstream' of the adaptor molecules CARMA1, Bcl-10 and MALT1 (refs”
BackgroundPDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation
Lee, K.-Y., D'Acquisto, F., Hayden, M. S., Shim, J.-H., & Ghosh, S. (2005) · Science · doi:10.1126/science.1107107 · Cited by 253
Helicobacter pylori and MALT Lymphoma
Farinha, P., & Gascoyne, R. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.083 · Cited by 243
Hailfinger, S., Nogai, H., Pelzer, C., Jaworski, M., Cabalzar, K., Charton, J.-E., Guzzardi, M., Décaillet, C., Grau, M., Dörken, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105020108 · Cited by 240
Self-citationC-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses
Kingeter, L. M., & Lin, X. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.58 · Cited by 240
Liu, F., Xia, Y., Parker, A. S., & Verma, I. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01107.x · Cited by 241
Antigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1
Thome, M., Charton, J. E., Pelzer, C., & Hailfinger, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003004 · Cited by 241
“2006), numerous studies support the critical function of activated NF-kB in the adaptive immune response (Li and Verma 2002; Thome 2004), and several recent studies document the contribution of CBM proteins to NF-kB activation (Rawlings et al.”
BackgroundSelf-citationNF-κB control of T cell development
Gerondakis, S., Fulford, T. S., Messina, N. L., & Grumont, R. J. (2014) · Nature Immunology · doi:10.1038/ni.2785 · Cited by 233
NFκB pathway: A good signaling paradigm and therapeutic target
Tergaonkar, V. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.023 · Cited by 235
SAP Regulates TH2 Differentiation and PKC-θ-Mediated Activation of NF-κB1
Cannons, J. L., Yu, L. J., Hill, B., Mijares, L. A., Dombroski, D., Nichols, K. E., Antonellis, A., Koretzky, G. A., Gardner, K., & Schwartzberg, P. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.012 · Cited by 231
T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1
Staal, J., Driege, Y., Bekaert, T., Demeyer, A., Muyllaert, D., Van Damme, P., Gevaert, K., & Beyaert, R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.85 · Cited by 219
“TCR or BCR stimulation triggers the phosphorylation of the CARDcontaining adaptor protein CARMA1 (also known as CARD11) by, respectively, protein kinase C (PKC) y or b (Thome, 2004).”
BackgroundZheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G., & Wu, H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.009 · Cited by 205
“MALT1) as a result of chromosomal translocation occurs frequently in MALT B cell lymphoma and mediates constitutive NF-kB activation (Thome, 2004).”
BackgroundOkkenhaug, K., Patton, D. T., Bilancio, A., Garçon, F., Rowan, W. C., & Vanhaesebroeck, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5122 · Cited by 205
“PKC also regulates a signaling pathway that leads to the nuclear translocation of NF- B subunits (6).”
BackgroundEssential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
Hailfinger, S., Lenz, G., Ngo, V., Posvitz-Fejfar, A., Rebeaud, F., Guzzardi, M., Penas, E.-M. M., Dierlamm, J., Chan, W. C., Staudt, L. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907511106 · Cited by 204
“C (also known as CARD11 or Bimp3), B-cell lymphoma-10 (BCL10) and Mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1 (MALT1) have an essential role in antigen receptor-induced nuclear factor- B (NF- B) activation and the control of lymphocyte activation and proliferation (1, 2).”
BackgroundSelf-citationFerch, U., Kloo, B., Gewies, A., Pfänder, V., Düwel, M., Peschel, C., Krappmann, D., & Ruland, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091167 · Cited by 203
“Lymphocyte-specific IKK and NF-B activation in response to normal antigen receptor signaling requires the immune cell–restricted CARD11–BCL10–MALT1 (CBM) complex consisting of the adapter proteins CARD11 (also called CARMA1) and BCL10 and the paracaspase MALT1 (Ruland and Mak, 2003; Thome, 2004).”
InfluentialGENETIC DISORDERS OF PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM
Bidère, N., Su, H. C., & Lenardo, M. J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090513 · Cited by 197
Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors
Minguet, S., Huber, M., Rosenkranz, L., Schamel, W. W. A., Reth, M., & Brummer, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200425524 · Cited by 197
The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes
Rawlings, D. J., Sommer, K., & Moreno-García, M. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1944 · Cited by 190
Gastrointestinal lymphoma: where morphology meets molecular biology
Isaacson, P. G., & Du, M. (2005) · The Journal of Pathology · doi:10.1002/path.1703 · Cited by 188
Molecular Pathogenesis of Mucosa-Associated Lymphoid Tissue Lymphoma
Farinha, P., & Gascoyne, R. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.011 · Cited by 184
Immune cell subset differentiation and tissue inflammation
Fang, P., Li, X., Dai, J., Cole, L., Camacho, J. A., Zhang, Y., Ji, Y., Wang, J., Yang, X.-F., & Wang, H. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0637-x · Cited by 183
Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists
Bacon, C. M., Du, M., & Doǧan, A. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.031146 · Cited by 182
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.005 · Cited by 178
“CARD11 is a major component of the “signalosome” complex, the coordinated recruitment of which is required for proper transduction of BCR signaling (Figure 3).(61) These events cluster in the exons encoding for the protein coiled-coil domain and enhance the ability of CARD11 to transactivate NF-κB target genes.”
PKCβ regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1
Shinohara, H., Yasuda, T., Aiba, Y., Sanjo, H., Hamadate, M., Watarai, H., Sakurai, H., & Kurosaki, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051591 · Cited by 165
“In addition to PKC , BCR stimulation requires adaptor molecules, CARMA1 (also known as caspase recruitment domain [CARD]11, Bimp3), Bcl10, and mucosal-associated lymphoid tissue (MALT)1, to activate NF- B (3, 20).”
BackgroundTyrosine kinases and their substrates in B lymphocytes
Kurosaki, T., & Hikida, M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00748.x · Cited by 160
“Given that B1 B cells dominantly express autoreactive BCR repertoire (144-146), these observations suggest that B1 B cells require comparatively strong BCR cross-linking and subsequent signaling for development and ⁄ or maintenance of B1 B cells.”
BackgroundBDCA2/FcεRIγ Complex Signals through a Novel BCR-Like Pathway in Human Plasmacytoid Dendritic Cells
Cao, W., Zhang, L., Rosen, D. B., Bover, L., Watanabe, G., Bao, M., Lanier, L. L., & Liu, Y.-J. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050248 · Cited by 162
Ye, H., Gong, L., Liu, H., Hamoudi, R., Shirali, S., Ho, L. K. F., Chott, A., Streubel, B., Siebert, R., Gesk, S., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1715 · Cited by 155
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development
Sagaert, X., Cutsem, E. V., Hertogh, G. D., Geboes, K., & Tousseyn, T. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.58 · Cited by 155
“This gene encodes a CARD-containing protein that has a key role in antigen-receptor signaling to NFκB”
BackgroundOcular adnexal lymphoma: a review of clinicopathologic features and treatment options
Decaudin, D., de Crémoux, P., Vincent‐Salomon, A., Dendale, R., & Rouïc, L. L.-L. (2006) · Blood · doi:10.1182/blood-2006-02-005017 · Cited by 151
Włodarska, I., Veyt, E., Paepe, P. D., Vandenberghe, P., Nooijen, P. T. G. A., Théate, I., Michaux, L., Sagaert, X., Marynen, P., Hagemeijer, A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403813 · Cited by 150
Phosphorylation of SNAP-23 by IκB Kinase 2 Regulates Mast Cell Degranulation
Suzuki, K., & Verma, I. M. (2008) · Cell · doi:10.1016/j.cell.2008.05.050 · Cited by 148
“Like TCR (Thome and Tschopp, 2003; Thome, 2004) or BCR (Thome, 2004), IKK2 is recruited into lipid rafts upon Fc3RI stimulation (Figure 4A).”
Concepts of activated T cell death
Brenner, D., Krammer, P. H., & Arnold, R. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.002 · Cited by 179
“[45] Thome M.”
BackgroundPathogenetic importance and therapeutic implications of NF‐κB in lymphoid malignancies
Lim, K., Yang, Y., & Staudt, L. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01105.x · Cited by 157
“Antigenic stimulation and engagement of NF-jB via an adapter complex involving CARD11, BCL10 and MALT1 (the CBM complex) is essential for the differentiation and ⁄ or maintenance of certain subpopulations of B cells, notably marginal zone and B1 B cells (60).”
BackgroundCaveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1
Ohnuma, K., Uchiyama, M., Yamochi, T., Nishibashi, K., Hosono, O., Takahashi, N., Kina, S., Tanaka, H., Lin, X., Dang, N. H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609157200 · Cited by 140
Jabara, H. H., Ohsumi, T. K., Chou, J. S., Massaad, M. J., Benson, H., Mégarbané, A., Chouery, É., Mikhael, R., Gorka, O., Gewies, A., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.047 · Cited by 139
“T-cell activation via the TCR or mitogenic stimuli such as phorbol myristic acid (PMA) and ionomycin (IO) results in activation of protein kinase C u, which phosphorylates CARMA1.(5) This enables recruitment of BCL-10 and MALT1, followed by oligomerization of the CARMA1/BCL-10/MALT1 (CBM) complex.”
Wu, C., de Miranda, N. F. C. C., Chen, L., Wasik, A. M., Mansouri, L., Jurczak, W. J., Gałązka, K., Długosz‐Danecka, M., Machaczka, M., Zhang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9500 · Cited by 141
“Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.”
BackgroundEssential Role for IκB Kinase β in Remodeling Carma1-Bcl10-Malt1 Complexes upon T Cell Activation
Wegener, E., Oeckinghaus, A., Papadopoulou, N., Lavitas, L.-M., Schmidt‐Supprian, M., Ferch, U., Mak, T. W., Ruland, J., Heissmeyer, V., & Krappmann, D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.027 · Cited by 142
Malignant pirates of the immune system
Rui, L., Schmitz, R., Ceribelli, M., & Staudt, L. M. (2011) · Nature Immunology · doi:10.1038/ni.2094 · Cited by 140
“The BCR may use the CBM complex to signal to NF-κB for the development and/or survival of marginal zone and B-1 cell”
MethodMultifunctional roles for MALT1 in T-cell activation
Thome, M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2338 · Cited by 131
Self-citationAntigen receptor signalling: a distinctive role for the p110δ isoform of PI3K
Okkenhaug, K., Ali, K., & Vanhaesebroeck, B. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.12.007 · Cited by 129
“DAG activates Ras guanyl nucleotide-releasing proteins (RasGRPs, which bind to Ca2+ and DAG) and isoforms of protein kinase C (PKC), which initiate the Ras–Erk–AP-1 and nuclear factor (NF)-κB signalling pathways, respectively [16–20].”
BackgroundRole of CD26/dipeptidyl peptidase IV in human T cell activation and function
Ohnuma, K. (2007) · Frontiers in bioscience · doi:10.2741/2844 · Cited by 131
A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways
Krappmann, D., & Scheidereit, C. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400380 · Cited by 128
“…)-mediated formation of a complex that consists of the CARMA1 (caspase recruitment domain-containing membrane-associated guanylate kinase protein 1), B-cell lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue (MALT1) proteins and transmits the signal to the IKK complex (Fig 2A; Thome, 2004).”
BackgroundKlemm, S., Gutermuth, J., Hültner, L., Sparwasser, T. D., Behrendt, H., Peschel, C., Mak, T. W., Jakob, T., & Ruland, J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051982 · Cited by 129
“Recently, the caspase recruitment domain protein B cell lymphoma 10 (Bcl10) and the paracaspase mucosa-associated lymphoid tissue 1 (Malt1) were identifi ed as key regulators of T cell and B cell antigen receptor signaling (15).”
BackgroundDefective immune responses in mice lacking LUBAC‐mediated linear ubiquitination in B cells
Sasaki, Y., Sano, S., Nakahara, M., Murata, S., Kometani, K., Aiba, Y., Sakamoto, S., Watanabe, Y., Tanaka, K., Kurosaki, T., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.184 · Cited by 133
“The CARMA1-BCL10-MALT1 (CBM) complex plays a central role in lymphocyte antigen receptor-mediated NF-k B activation (Thome, 2004).”
ORIGINAL ARTICLE: The Transcriptome of the Fetal Inflammatory Response Syndrome
Madsen‐Bouterse, S. A., Romero, R., Tarca, A. L., Kusanovic, J. P., Espinoza, J., Kim, C. J., Kim, J., Edwin, S. S., Gomez, R., & Draghici, S. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00791.x · Cited by 121
Sato, S., Sanjo, H., Tsujimura, T., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Takeuchi, O., & Akira, S. (2006) · International Immunology · doi:10.1093/intimm/dxl082 · Cited by 130
“B cell receptor (BCR) stimulation triggers the rapid activation of protein kinase C (PKC)-b, and it transduces signals via a complex composed of CARD11, Bcl10 and MALT1, leading to the activation of the IKK complex ( 7 ).”
BackgroundPKCζ at the crossroad of NF-κB and Jak1/Stat6 signaling pathways
Moscat, J., Rennert, P. D., & Díaz-Meco, M. T. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401823 · Cited by 137
A Scaffold Protein, AHNAK1, Is Required for Calcium Signaling during T Cell Activation
Matza, D., Badou, A., Kobayashi, K. S., Goldsmith‐Pestana, K., Masuda, Y., Komuro, A., McMahon‐Pratt, D., Marchesi, V. T., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.020 · Cited by 126
Naylor, T. L., Tang, H., Ratsch, B. A., Enns, A., Loo, A. T., Chen, L., Lenz, P., Waters, N. J., Schüler, W., Dörken, B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2525 · Cited by 119
“A CARD11 mutant construct lacking the CARD domain, which is crucial to facilitate CBM complex assembly (31), could not confer resistance to PKC inhibitors (Supplementary Fig.”
Hamilton, K. S., Phong, B. L., Corey, C. G., Cheng, J., Gorentla, B. K., Zhong, X., Shiva, S., & Kane, L. (2014) · Science Signaling · doi:10.1126/scisignal.2005169 · Cited by 134
“MALT1, but not Bcl10, mediates the TCR- and CD28-dependent activation of mTOR signaling Activation of NF-kB by Carma1 is mediated by at least two other proteins: Bcl10 and MALT1 (37).”
BackgroundAn integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins
Yuan, W., Xia, Y., Bell, C. G., Yet, İ., Ferreira, T. C., Ward, K. J., Gao, F., Loomis, A. K., Hyde, C. L., Wu, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6719 · Cited by 123
Round, J. L., Humphries, L. A., Tomassian, T., Mittelstadt, P. R., Zhang, M., & Miceli, M. C. (2006) · Nature Immunology · doi:10.1038/ni1422 · Cited by 126
“Our findings emphasize the importance of MAGUK family scaffolds in 'translating' early TCR signals into specific downstream activities, probably by organizing 'signalosomes' in the synaps”
BackgroundDybkær, K., Iqbal, J., Zhou, G., Geng, H., Xiao, L., Schmitz, A., d’Amore, F., & Chan, W. C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-230 · Cited by 118
Groß, O., Grupp, C., Steinberg, C., Zimmermann, S., Strasser, D., Hannesschläger, N., Reindl, W., Jonsson, A. H., Huo, H., Littman, D. R., et al. (2008) · Blood · doi:10.1182/blood-2007-11-123513 · Cited by 117
CARD9 versus CARMA1 in innate and adaptive immunity
Hara, H., & Saito, T. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.002 · Cited by 118
Bcl10 and Malt1 control lysophosphatidic acid-induced NF-κB activation and cytokine production
Klemm, S., Zimmermann, S., Peschel, C., Mak, T. W., & Ruland, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608388103 · Cited by 123
Assembly mechanism of the CARMA1–BCL10–MALT1–TRAF6 signalosome
David, L., Li, Y., Ma, J., Garner, E. C., Zhang, X., & Wu, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721967115 · Cited by 119
“TCR- and BCR-induced NF-κB signaling has a crucial role in regulating the activation, proliferation, and effector functions of lymphocytes in adaptive immune responses (16, 17).”
BackgroundRegulation of NF-κB signaling by caspases and MALT1 paracaspase
Staal, J., Bekaert, T., & Beyaert, R. (2010) · Cell Research · doi:10.1038/cr.2010.168 · Cited by 114
The pathogenesis of MALT lymphomas: where do we stand?
Sagaert, X., Wolf-Peeters, C. D., Noels, H., & Baens, M. (2007) · Leukemia · doi:10.1038/sj.leu.2404517 · Cited by 108
Discs large (Dlg1) complexes in lymphocyte activation
Xavier, R., Rabizadeh, S., Ishiguro, K., Andre, N., Ortiz, J. B., Wachtel, H., Morris, D. G., Lopez-Ilasaca, M., Shaw, A. C., Swat, W., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309044 · Cited by 107
“Compromise of expression of the MAGUK protein, CARMA-1, by germline targeting, somatic mutation, or RNA interference inhibits antigen receptor mediated NF- B activation (Jun and Goodnow, 2003; Thome, 2004).”
BackgroundShinohara, H., Maeda, S., Watarai, H., & Kurosaki, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070379 · Cited by 111
Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity
Torres, J. M., Martínez‐Barricarte, R., García-Gómez, S., Mazariegos, M. S., Itan, Y., Boisson, B., ρlvarez, R., Jiménez-Reinoso, A., Molina, L. D. P., Rodríguez‐Pena, R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77493 · Cited by 106
Ca 2+ /Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-κB Activation
Ishiguro, K., Green, T. J., Rapley, J., Wachtel, H., Giallourakis, C. C., Landry, A. L., Cao, Z., Lu, N., Ando, T., Goto, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02469-05 · Cited by 111
“CARMA1, a member of the MAGUK family of kinases, encodes a protein that contains a caspase recruitment domain (CARD), a coiled-coil domain, a PDZ domain, a Src homology 3 (SH3) domain, and a C-terminal guanylate kinase domain (42).”
BackgroundInfluentialChronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type
Thiéblemont, C., Bertoni, F., Copie‐Bergman, C., Ferreri, A. J. M., & Ponzoni, M. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.005 · Cited by 102
Castermans, D., Volders, K., Crepel, A., Backx, L., De Vos, R., Freson, K., Meulemans, S., Vermeesch, J. R., Schrander-Stumpel, C. T. R. M., De Rijk, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq013 · Cited by 100
“As expected, we observed no effect with the shRNA construct for human MALT1 (31), as it does not have a target in mouse.”
BackgroundCombined Immunodeficiency Due to MALT1 Mutations, Treated by Hematopoietic Cell Transplantation
Punwani, D., Wang, H., Chan, A. Y. K., Cowan, M. J., Mallott, J. M., Sunderam, U., Mollenauer, M. N., Srinivasan, R., Brenner, S. E., Mulder, A., et al. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0125-1 · Cited by 108
“While the precise molecular mechanisms are still not completely clear, stimulation through the Tcell and B cell receptors causes phosphorylation of CARMA1, recruitment ofMALT1 and BCL-10, and oligomerization of components of the CBM complex [12–14].”
Backgroundvan Keimpema, M., Grüneberg, L. J., Mokrý, M., van Boxtel, R., Köster, J., Coffer, P. J., Pals, S. T., & Spaargaren, M. (2014) · Blood · doi:10.1182/blood-2014-01-553412 · Cited by 101
“Activation of various receptors, such as the B-cell receptor (BCR), CD40, or Toll-like receptors, will lead to formation of the CARD11BCL10-MALT1 signaling complex, which results in the activation of the NF-kB pathway.(17) A large proportion of MALT lymphomas express a BCR with rheumatoid factor activity, which is con…”
Kelly, E. K., Wang, L., & Ivashkiv, L. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901293 · Cited by 96
“ITAM-dependent signaling activates a calcium flux via activation of phospholipase Cg (PLCg) and uses caspase recruitment domain adaptor proteins Carma1 (in lymphocytes) or CARD9 (in DCs, downstream of Dectin-1) to activate NF-kB and MAPK pathways (10, 13, 14).”
Metadata
- Authors
- Thome, M.
- Affiliations
- University of Lausanne (CH)
- Corresponding author
- Thome, Margot
- ORCID
- Thome, Margot
- Venue
- Nature Reviews Immunology
- Published
- 2004-05
- Volume
- 4
- Issue
- 5
- Pages
- 348-359
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2018705412
- Cited by
- 391
- References
- 114
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 11 · 2020: 8 · 2019: 12 · 2018: 17 · 2017: 8 · 2016: 18 · 2015: 8 · 2014: 16 · 2013: 19 · 2012: 20
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Oncosuisse
- Krebsliga Schweiz
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- CARMA1, BCL10, MALT1, NF-κB signaling, lymphocyte development, B cell development, T cell development, lipopolysaccharide, B cell activation
- MeSH terms
- B-Cell CLL-Lymphoma 10 Protein, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Animals, B-Lymphocytes, Carrier Proteins, Guanylate Cyclase, Humans, Lymphocyte Activation, Membrane Proteins, Neoplasm Proteins, T-Lymphocytes, Signal Transduction, NF-kappa B, Mice, Knockout, Lymphoma, B-Cell, Marginal Zone, Caspases, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.